Li Lai: Alzheimer's new drug Kisunla approved for market in European Union.

On September 25th local time, Eli Lilly and Company announced that the European Commission has approved the listing of its Alzheimer's disease treatment drug Kisunla, which is used for treating specific cases of early symptomatic Alzheimer's disease.